Identifying subgroup markers in heterogeneous populations
Open Access
- 20 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (21), e200
- https://doi.org/10.1093/nar/gkt845
Abstract
Traditional methods that aim to identify biomarkers that distinguish between two groups, like Significance Analysis of Microarrays or the t-test, perform optimally when such biomarkers show homogeneous behavior within each group and differential behavior between the groups. However, in many applications, this is not the case. Instead, a subgroup of samples in one group shows differential behavior with respect to all other samples. To successfully detect markers showing such imbalanced patterns of differential signal, a different approach is required. We propose a novel method, specifically designed for the Detection of Imbalanced Differential Signal (DIDS). We use an artificial dataset and a human breast cancer dataset to measure its performance and compare it with three traditional methods and four approaches that take imbalanced signal into account. Supported by extensive experimental results, we show that DIDS outperforms all other approaches in terms of power and positive predictive value. In a mouse breast cancer dataset, DIDS is the only approach that detects a functionally validated marker of chemotherapy resistance. DIDS can be applied to any continuous value data, including gene expression data, and in any context where imbalanced differential signal is manifested.This publication has 14 references indexed in Scilit:
- Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachBreast Cancer Research, 2012
- Do predictive signatures really predict response to cancer chemotherapy?Cell Cycle, 2010
- Effect of training-sample size and classification difficulty on the accuracy of genomic predictorsBreast Cancer Research, 2010
- Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseBreast Cancer Research and Treatment, 2009
- MOST: detecting cancer differential gene expressionBiostatistics, 2007
- Cancer outlier differential gene expression detectionBiostatistics, 2006
- COPA—cancer outlier profile analysisBioinformatics, 2006
- Outlier sums for differential gene expression analysisBiostatistics, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001